Trial Profile
Prevalence of Methicillin-resistant Staphylococcus Aureus (MRSA) in a Medical Center and Efficacy of Altabax in Clearing MRSA Nasal Colonization
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 08 Sep 2023
Price :
$35
*
At a glance
- Drugs Retapamulin (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections
- Focus Therapeutic Use
- 10 Mar 2009 New trial record